Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06828354 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of SHR-A1811 in Subjects With Ovarian Cancer

Name: A Study of SHR-A1811 in Subjects With Ovarian Cancer — clinical trial record (NCT06828354)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorJiangsu HengRui Medicine Co., Ltd.

Started2025-03-13

View on ClinicalTrials.gov ↗

Amendment history

2026-04-15

Study Status v2

Re-verified, no change to tracked fields

2025-03-21

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2025-02→confirmed 2025-03-13

Study sitesdetails revised at 2 of 2 sites

2025-02-10

Original filing

Jiangsu HengRui Medicine Co., Ltd.

126 trials monitored

See 6 trials at risk

Ovarian Cancer

1,239 trials monitored

See 74 trials at risk

This is an open-label study to evaluate the safety and efficacy of SHR-A1811 for injection in subjects with ovarian cancer.

Trial Details

NCT Number	NCT06828354
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	Ovarian Cancer
Enrollment	300 participants
Start Date	2025-03-13
Primary Completion	2027-05 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-20